Gratus Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Gratus Wealth Advisors's ABBV Position: Q3 2026 in Review
Gratus Wealth Advisors reduced its AbbVie (ABBV) stake by 4.7% in Q3 2026, selling an estimated $77.2K and leaving 6,105 shares worth $1.6M. The position accounts for 0.2% of the portfolio, ranked #36.
Gratus Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.61M in Q2 2026. 3,877 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Gratus Wealth Advisors held 6,105 shares of AbbVie worth $1.6M as of Q3 2026.
- Gratus Wealth Advisors sold 301 AbbVie shares in Q3 2026, an estimated $77.2K.
- AbbVie made up 0.2% of Gratus Wealth Advisors's portfolio in Q3 2026, its #36 holding.
- Gratus Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
- Gratus Wealth Advisors's AbbVie position peaked at $1.61M in Q2 2026.
- 3,877 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Gratus Wealth Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.